Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1171 to 1185 of 1688 results for carers

  1. Community pharmacies: promoting health and wellbeing (QS196)

    This quality standard covers how community pharmacies can support the health and wellbeing of the local population. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    28 August 2020
    View quality statements

    Sections for QS196

  2. Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions (MIB15)

    NICE has developed a Medtech Innovation Briefing (MIB) on Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions

    Medtech innovation briefing
    Published
    16 December 2014

  3. Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (IPG355)

    Evidence-based recommendations on endoscopic submucosal dissection (ESD) of oesophageal dysplasia and neoplasia. This involves inserting a long camera through the mouth into the oesophagus to view the area and removing the abnormal part with special instruments.

    Interventional procedures guidance
    Published
    22 September 2010
    View recommendations

    Sections for IPG355

  4. Incisionless otoplasty (IPG422)

    Evidence-based recommendations on incisionless otoplasty. This involves using a hollow needle to divide the ear cartilage, and using stitches buried under the skin to remould the ear.

    Interventional procedures guidance
    Published
    27 March 2012
    View recommendations

    Sections for IPG422

  5. Voclosporin with mycophenolate mofetil for treating lupus nephritis (TA882)

    Evidence-based recommendations on voclosporin (Lupkynis) with mycophenolate mofetil for treating lupus nephritis in adults.

    Technology appraisal guidance
    Published
    3 May 2023
    View recommendations

    Sections for TA882

  6. Cladribine for treating relapsing–remitting multiple sclerosis (TA616)

    Evidence-based recommendations on cladribine (Mavenclad) for relapsing–remitting multiple sclerosis in adults.

    Technology appraisal guidance
    Last updated
    21 May 2024
    View recommendations

    Sections for TA616

  7. Relationship between attachment difficulties and complex trauma:- This research recommendation is composed of 2 parts:Assess the prevalence of attachment difficulties (including attachment disorders), complex trauma and the combination of both in children and young people in the care system and on the edge of care.Investigate the effect of various factors, such as multiple placements, on the likelihood of having attachment difficulties, complex trauma or both.

    complex trauma or both.Primary outcome measures may include:- attachment- carer sensitivity- placement disruption- complex trauma.A...

    Research recommendation
    Published
    11 December 2015

  8. The NICE public health guidance development process (third edition) (PMG5)

    The NICE public health guidance development process (third edition)

  9. Communicating information about drug allergy:- In people with suspected or confirmed drug allergies, are patient-focused information strategies more effective than standard NHS practice in increasing people's likelihood of disclosing their drug allergy (or their suspected drug allergy) and therefore reducing the risk of being re-exposed to the affected drug?

    be lost when patients move to new areas. Patients and their families and carers have been identified as a resource to prevent...

    Research recommendation
    Published
    9 June 2015

  10. Evidence on the efficacy and safety of neurostimulation of lumbar muscles for refractory non-specific chronic low back pain is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    leads in their healthcare organisation.• Give people (and their families and carers as appropriate) clear written information to support...

    Research recommendation
    Published
    30 September 2022

  11. Evidence on the safety and efficacy of prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    leads in their healthcare organisation.• Give people (and their families and carers as appropriate) clear written information to support...

    Research recommendation
    Published
    30 September 2022

  12. Obesity: clinical assessment and management (QS127)

    This quality standard covers assessing and managing obesity in adults, young people and children, including referral for specialist care and bariatric (weight loss) surgery. It includes people who are obese and have, or are at risk of, other medical conditions. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    4 August 2016
    View quality statements

    Sections for QS127

  13. Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence (IPG393)

    Evidence-based recommendations on endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence. This involves applying radiofrequency energy to the anal wall, with the aim of inducing muscle changes to improve muscle tone and help control bowel movement.

    Interventional procedures guidance
    Published
    25 May 2011
    View recommendations

    Sections for IPG393

  14. Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit.  Find out  what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research.   Find out  what only in research means on the NICE interventional procedures guidance page .

    their healthcare organisation. Give patients (and their families and carers as appropriate) clear written information to support shared...

    Research recommendation
    Published
    22 January 2021

  15. Guide to the technology appraisal and highly specialised technologies appeal process (PMG41)

    Guide to the technology appraisal and highly specialised technologies appeal process